Abstract

We conclude that platelet activation occurs in vivo in patients undergoing DSE and that this may be caused by a synergistic effect of dobutamine with physiologic platelet agonists.

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/02/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/9588422